186 results on '"neurological diseases"'
Search Results
2. Association Between COVID-19 and Neurological Diseases: Evidence from Large-Scale Mendelian Randomization Analysis and Single-Cell RNA Sequencing Analysis
3. Advances and challenges in serine in the central nervous system: physicochemistry, physiology, and pharmacology
4. Mechanisms of cuproptosis and its relevance to distinct diseases
5. The Role of PKM2 in Multiple Signaling Pathways Related to Neurological Diseases
6. A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological research
7. Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
8. Reduced tear fluid production in neurological diseases: a cohort study in 708 patients
9. Neurological hospitalisations in childhood cancer survivors treated before 2001: findings from the French Childhood Cancer Survivor Study cohort
10. Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis
11. Advancement in modulation of brain extracellular space and unlocking its potential for intervention of neurological diseases
12. The α-tubulin acetyltransferase ATAT1: structure, cellular functions, and its emerging role in human diseases
13. LXR agonism for CNS diseases: promises and challenges
14. Genetic causal role of body mass index in multiple neurological diseases
15. Association between urinary glyphosate levels and serum neurofilament light chain in a representative sample of US adults: NHANES 2013–2014
16. Bioactive Compounds of the Genus Spirulina Can Prevent the Progression of Neurological Diseases
17. The Rotterdam Study. Design update and major findings between 2020 and 2024
18. Therapeutic use of medical Cannabis in neurological diseases: a clinical update
19. eHealth tools to assess the neurological function for research, in absence of the neurologist – a systematic review, part I (software)
20. Physioland: a motivational complement of physical therapy for patients with neurological diseases
21. Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches
22. Intranasal administration nanosystems for brain-targeted drug delivery
23. The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review
24. Bone Marrow-Derived Mononuclear Cells in the Treatment of Neurological Diseases: Knowns and Unknowns
25. Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data
26. Symptoms and problems reported by patients with non-cancer diseases through open-ended questions in specialist palliative care: a national register-based study
27. Biosensors, Recent Advances in Determination of BDNF and NfL
28. Outcome of patients older than 85 years hospitalized in a neurology unit
29. IVIg-induced headache: prospective study of a large cohort with neurological disorders
30. The Promise of Niacin in Neurology
31. Selected Biomarkers of Oxidative Stress and Energy Metabolism Disorders in Neurological Diseases
32. Role of the Voltage-Gated Proton Channel Hv1 in Nervous Systems
33. The applied principles of EEG analysis methods in neuroscience and clinical neurology
34. Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint
35. Functional nanoparticle-enabled non-genetic neuromodulation
36. Orofacial function and temporomandibular disorders in Parkinson’s Disease: a case-controlled study
37. The Node of Ranvier as an Interface for Axo-Glial Interactions: Perturbation of Axo-Glial Interactions in Various Neurological Disorders
38. Neuroprotective Roles of Apelin-13 in Neurological Diseases
39. Urinary di-(2-ethylhexyl) phthalate metabolites are independently related to serum neurofilament light chain, a biomarker of neurological diseases, in adults: results from NHANES 2013–2014
40. The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
41. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system
42. Formulation and evaluation of magnesium sulphate nanoparticles for improved CNS penetrability
43. MicroRNA: Crucial modulator in purinergic signalling involved diseases
44. Initiation of dendritic NMDA spikes co-regulated via distance-dependent and dynamic distribution of the spine number and morphology in neuron dendrites
45. CRISPR: a tool with potential for genomic reprogramming in neurological disorders
46. Application of Ultrasonography in Neurogenic Dysphagia: A Systematic Review
47. Role of SIRT3 in neurological diseases and rehabilitation training
48. Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease
49. Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens
50. Role of Neural Stem Cells and Vitamin D Receptor (VDR)–Mediated Cellular Signaling in the Mitigation of Neurological Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.